These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27633510)

  • 1. Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Tao Q; Zhang Y
    Lipids Health Dis; 2016 Sep; 15(1):158. PubMed ID: 27633510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus.
    Zhang PH; Gao JL; Pu C; Feng G; Wang LZ; Huang LZ; Zhang Y
    Lipids Health Dis; 2016 Aug; 15(1):142. PubMed ID: 27576735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
    Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
    J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome.
    He L; Wu P; Tan L; Le B; Du W; Shen T; Wu J; Xiang Z; Hu M
    Lipids Health Dis; 2017 Sep; 16(1):167. PubMed ID: 28877724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
    Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
    Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes.
    Kumaraswamy SB; Linder A; Åkesson P; Dahlbäck B
    Crit Care; 2012 Dec; 16(2):R60. PubMed ID: 22512779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between apolipoprotein M and insulin resistance varies with country of birth.
    Memon AA; Bennet L; Zöller B; Wang X; Palmér K; Dahlbäck B; Sundquist J; Sundquist K
    Nutr Metab Cardiovasc Dis; 2014 Nov; 24(11):1174-80. PubMed ID: 24984825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
    Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
    Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum apolipoprotein M level.
    Tanaka S; Okamoto Y
    Clin Lab; 2011; 57(9-10):803-6. PubMed ID: 22029201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
    Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
    Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.
    Christoffersen C; Jauhiainen M; Moser M; Porse B; Ehnholm C; Boesl M; Dahlbäck B; Nielsen LB
    J Biol Chem; 2008 Jan; 283(4):1839-47. PubMed ID: 18006500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein status in type 2 diabetes mellitus and its complications (Review).
    Zhang P; Gao J; Pu C; Zhang Y
    Mol Med Rep; 2017 Dec; 16(6):9279-9286. PubMed ID: 29152661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High apolipoprotein M serum levels correlate with chronic obstructive pulmonary disease.
    Li H; Liu Y; Wang L; Shen T; Du W; Liu Z; Chen R; Hu M
    Lipids Health Dis; 2016 Mar; 15():59. PubMed ID: 27001252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
    Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study.
    Brouwers MC; Troutt JS; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schaper NC; Schalkwijk CG; Konrad RJ; Stehouwer CD
    Atherosclerosis; 2011 Jul; 217(1):263-7. PubMed ID: 21497351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
    Mughal SA; Park R; Nowak N; Gloyn AL; Karpe F; Matile H; Malecki MT; McCarthy MI; Stoffel M; Owen KR
    Diabet Med; 2013 Feb; 30(2):246-50. PubMed ID: 23157689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus.
    Kappelle PJ; Ahnström J; Dikkeschei BD; de Vries R; Sluiter WJ; Wolffenbuttel BH; van Tol A; Nielsen LB; Dahlbäck B; Dullaart RP
    Atherosclerosis; 2010 Nov; 213(1):247-50. PubMed ID: 20828695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects.
    Kappelle PJ; Lambert G; Dahlbäck B; Nielsen LB; Dullaart RP
    Atherosclerosis; 2011 Feb; 214(2):492-4. PubMed ID: 21122852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.